Loading…
Advanced Safe Testing at Residence Telehealth Act of 2021
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
74pct
48d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Advanced Safe Testing at Residence Telehealth Act of 2021 This bill temporarily establishes several programs to provide telehealth services for at-home testing, evaluations, and other health care. Specifically, the bill establishes a demonstration program to provide assistive telehealth consultations and home- and community-based care for certain Medicare beneficiaries through Medicare Advantage (MA) plans. Covered services include certain at-home diagnostic tests, telehealth consultations, transportation services, and meal benefits. Beneficiaries must be (1) age 65 or older and eligible to enroll in a qualifying MA plan and to receive certain low-income subsidies under the Medicare prescription drug benefit, or (2) dually eligible for Medicare and Medicaid benefits. The bill also establishes a grant program for state Medicaid programs to cover similar at-home tests and related telehealth consultations. Additionally, the Department of Veterans Affairs must establish a pilot program to provide tests and related telehealth consultations free of charge to veterans.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2022 · first_quarter · Health Issues
Issues related to stroke care and routing protocol policies pertaining to emergent large vessel occlusion stroke. Issues related to telemedicine and remote patient monitoring, including H.R.4670 - Advanced Safe Testing at Residence Telehealth Act of 2021. Issues related to global medical supply chains. Issues related to H.R. 6000, Cures 2.0 Act. Issues related to opioid-induced respiratory compromise continuous patient monitoring, including H.R. 5932 - Inpatient Opioid Safety Act of 2021. H.R. 7084 / S. 3983 - PATCH Act of 2022 Issues related to disparities of care. Issues pertaining to FDA, including medical device user fee reauthorization, certificates to foreign government, change control protocols, emerging signals, electronic labeling, and shortage reporting. Issues related to the sterilization of medical devices. Issues related to digital health, data interoperability, and electronic health records. Issues related to servicing and repair of medical devices Issues related to ONC and CMS implementation of effective and efficient interoperability standards. Support for the Cardiovascular Advances in Research and Opportunity Legacy (CAROL) Act (H.R. 1193 and S. 1133).
Referred to the Subcommittee on Technology Modernization.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $870,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Medicare/Medicaid
Issues related to Medicare policies on continuous glucose monitors and closed loop systems. Issues related to opioid-induced respiratory compromise continuous patient monitoring, including H.R. 5932 - Inpatient Opioid Safety Act of 2021. Issues pertaining to FY22 Inpatient Rule and LITT DRG reassignment. Issue related to Medicare coverage and payment for Breakthrough-designated medical devices, including H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act. Issues related to telemedicine and remote patient monitoring, including H.R.4670 - Advanced Safe Testing at Residence Telehealth Act of 2021. Issues related to non-opioid pain therapies. Issues related to Medicare coverage of digital health technologies. Issues pertaining to Medicare provider payment cuts.
Client expense: $870,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
Issues related to the sterilization of medical devices. Issues related to digital health, data interoperability, and electronic health records. Issues related to medical devices and COVID-19. Issues related to stroke care and routing protocol policies pertaining to emergent large vessel occlusion stroke. H.R. 5663, Safeguarding Therapeutics Act. Issues related to telemedicine and remote patient monitoring, including H.R.4670 - Advanced Safe Testing at Residence Telehealth Act of 2021. Issues related to global medical supply chains. Issues related to H.R. 6000, Cures 2.0 Act. Issues related to servicing of medical devices. Issues related to ONC and CMS implementation of effective and efficient interoperability standards. Issues related to opioid-induced respiratory compromise continuous patient monitoring, including H.R. 5932 - Inpatient Opioid Safety Act of 2021. Issues related to disparities of care. Support for the Cardiovascular Advances in Research and Opportunity Legacy (CAROL) Act (H.R. 1193 and S. 1133). Issue related to H.R. 5376, Build Back Better Act. Issues pertaining to FDA, including medical device user fee reauthorization.
Client expense: $800,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Pipeline & Hazardous Materials Safety Administration, SENATE, Transportation, Dept of (DOT), White House Office
2021 · fourth_quarter · Medicare/Medicaid
Issues related to Medicare policies on continuous glucose monitors and closed loop systems. Issues related to opioid-induced respiratory compromise continuous patient monitoring, including H.R. 5932 - Inpatient Opioid Safety Act of 2021. Issues pertaining to FY22 Inpatient Rule and LITT DRG reassignment. Issue related to Medicare coverage and payment for Breakthrough-designated medical devices, including H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act. Issues related to telemedicine and remote patient monitoring, including H.R.4670 - Advanced Safe Testing at Residence Telehealth Act of 2021. Issues related to non-opioid pain therapies, including H.R. 3259/S. 586 (NOPAIN Act) and H.R. 4098/S. 1292 (Non-Opioid Directive Act). Issues related to Medicare coverage of digital health technologies. Issues pertaining to Medicare provider payment cuts. Issue related to H.R. 5376, Build Back Better Act.
Client expense: $800,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Pipeline & Hazardous Materials Safety Administration, SENATE, Transportation, Dept of (DOT), White House Office